[VIEW] agent=Oncology Research Program Manager | scenario_id=117 | rounds=20

--- Round 0 ---
[R0.1] Data Governance & Privacy Officer (speak, public): To proceed with the oncology outcomes registry program, I need to confirm the specific data elements you require for this project, the proposed delivery cadence, and the details of how the data transfer workflow will be implemented. Additionally, are there any potential high-risk content requests or unresolved security concerns that we should address?
[R0.2] Oncology Research Program Manager (speak, public): The key data elements required for the project include 38 fields that encompass staging and regimen details, while imaging files will be excluded. We propose a quarterly submission schedule with a 14-day window after each quarter-end for data transfer. As for the data transfer workflow, we need to ensure that the architecture is secure and compliant with privacy regulations. I would like to confirm if there are any additional details regarding the governance and contracting path that we should address, as well as any potential compliance issues we should be aware of.
[R0.3] Enterprise Data Platform & Security Lead (speak, public): To achieve compliance and ensure a secure data transfer, I can confirm that our data pipeline will utilize Azure Data Lake Gen2 with SFTP drops and PGP encryption using a 4096-bit key. Additionally, we will follow a service principal access control pattern with the least privilege model, and all outbound traffic will be restricted according to our IP allowlist. Regarding your questions, could you clarify any specific governance-driven handling requirements or unusual content requests we should be aware of? This will help us ensure the implementation aligns with your expectations.

--- Round 1 ---
[R1.1] Data Governance & Privacy Officer (speak, public): To ensure we are fully prepared, I want to share that we have a de-identification standard in place which uses expert determination with a minimum cell size of 11 and dates shifted by ±14 days. Additionally, I want to confirm that our permitted dataset elements for the registry extract include 38 structured fields with direct identifiers removed, and that the MRN will be replaced with a 12-character token. Lastly, please let me know if there are any high-risk content requests or unresolved security concerns that remain, as it's crucial for our compliance and operational effectiveness.
[R1.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): Thank you for the updates. I believe we have a solid foundation regarding the data elements and the secure transfer architecture. However, I still need confirmation on the governance and contracting path as well as any practical delivery constraints that we need to be aware of. Are there any updates on those aspects?
[R1.3] Enterprise Data Platform & Security Lead (speak, private to=Data Governance & Privacy Officer,Oncology Research Program Manager): To proceed effectively, could you clarify any specific governance-driven handling requirements or unusual content requests that we should be aware of? Additionally, I would like to confirm if there are any updates regarding the governance and contracting path and any practical delivery constraints that might impact our timeline.

--- Round 2 ---
[R2.1] Data Governance & Privacy Officer (speak, private to=Oncology Research Program Manager,Enterprise Data Platform & Security Lead): To address the governance and contracting path, I can confirm that we currently have a Data Use Agreement (DUA) v3 in progress, with 11 clauses agreed upon and 3 still open. These include rediscclosure, audit rights, and the requirement for destruction of data within 30 days. It’s crucial to finalize these before moving forward. Additionally, I would like to discuss any potential high-risk content requests you anticipate and ensure we are aligned on any unresolved security concerns that could impact our compliance and operational readiness.
[R2.2] Oncology Research Program Manager (speak, private to=Data Governance & Privacy Officer,Enterprise Data Platform & Security Lead): Thank you for the update on the DUA v3 status. It’s good to know that we're making progress with the clauses. Regarding high-risk content requests, I believe we don’t have any on our end. Could we also confirm the practical delivery constraints that might impact our timeline? This will help us ensure that we stay aligned as we move forward.
[R2.3] Enterprise Data Platform & Security Lead (speak, public): Thank you for the clarifications regarding the DUA v3 and the handling of high-risk content. Based on our current discussions, it seems we have a solid foundation for moving forward. However, I still need precise expectations regarding the volume and timing of data submissions to ensure our data transfer architecture can support it effectively. Can we confirm these details?

--- Round 3 ---
[R3.1] Data Governance & Privacy Officer (leave, public): 
[R3.2] Oncology Research Program Manager (leave, public): 
[R3.3] Enterprise Data Platform & Security Lead (leave, public): I appreciate the collaboration and insights shared. Let's follow up on the final details regarding volume and timing as soon as possible to ensure we stay on track for implementation.

--- Round 4 ---
[R4.1] Data Governance & Privacy Officer (leave, public): 
[R4.2] Oncology Research Program Manager (leave, public): 
[R4.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 5 ---
[R5.1] Data Governance & Privacy Officer (leave, public): 
[R5.2] Oncology Research Program Manager (leave, public): 
[R5.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 6 ---
[R6.1] Data Governance & Privacy Officer (leave, public): 
[R6.2] Oncology Research Program Manager (leave, public): 
[R6.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 7 ---
[R7.1] Data Governance & Privacy Officer (leave, public): 
[R7.2] Oncology Research Program Manager (leave, public): 
[R7.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 8 ---
[R8.1] Data Governance & Privacy Officer (leave, public): 
[R8.2] Oncology Research Program Manager (leave, public): 
[R8.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 9 ---
[R9.1] Data Governance & Privacy Officer (leave, public): 
[R9.2] Oncology Research Program Manager (leave, public): 
[R9.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 10 ---
[R10.1] Data Governance & Privacy Officer (leave, public): 
[R10.2] Oncology Research Program Manager (leave, public): 
[R10.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 11 ---
[R11.1] Data Governance & Privacy Officer (leave, public): 
[R11.2] Oncology Research Program Manager (leave, public): 
[R11.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 12 ---
[R12.1] Data Governance & Privacy Officer (leave, public): 
[R12.2] Oncology Research Program Manager (leave, public): 
[R12.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 13 ---
[R13.1] Data Governance & Privacy Officer (leave, public): 
[R13.2] Oncology Research Program Manager (leave, public): 
[R13.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 14 ---
[R14.1] Data Governance & Privacy Officer (leave, public): 
[R14.2] Oncology Research Program Manager (leave, public): 
[R14.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 15 ---
[R15.1] Data Governance & Privacy Officer (leave, public): 
[R15.2] Oncology Research Program Manager (leave, public): 
[R15.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 16 ---
[R16.1] Data Governance & Privacy Officer (leave, public): 
[R16.2] Oncology Research Program Manager (leave, public): 
[R16.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 17 ---
[R17.1] Data Governance & Privacy Officer (leave, public): 
[R17.2] Oncology Research Program Manager (leave, public): 
[R17.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 18 ---
[R18.1] Data Governance & Privacy Officer (leave, public): 
[R18.2] Oncology Research Program Manager (leave, public): 
[R18.3] Enterprise Data Platform & Security Lead (leave, public): 

--- Round 19 ---
[R19.1] Data Governance & Privacy Officer (leave, public): 
[R19.2] Oncology Research Program Manager (leave, public): 
[R19.3] Enterprise Data Platform & Security Lead (leave, public): 

